menu
    • menu

    Company profile for Xenon Pharmaceuticals Inc

    NEW Drugs in Dev: 11
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Xenon is focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Our goal is to build a self-sustaining, fully-integrated, and profitable company that discovers, develops and commercializes innovative CNS therapeutics, including novel, selective ion channel modulators. We intend to expand our pipeline with therapeutic candidates from our internal research efforts and through ...
    Xenon is focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Our goal is to build a self-sustaining, fully-integrated, and profitable company that discovers, develops and commercializes innovative CNS therapeutics, including novel, selective ion channel modulators. We intend to expand our pipeline with therapeutic candidates from our internal research efforts and through the acquisition or in-licensing of other technologies or product candidates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Xenon Pharmaceuticals IncCanada Flag
    Country
    Country
    Canada
    Address
    Address
    3650 Gilmore Way Burnaby, BC V5G 4W8
    Telephone
    Telephone
    +6044843300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xenon-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xenon-pharmaceuticals-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xenon Reports Q1 2026 Results and Business Update
    Xenon Reports Q1 2026 Results and Business Update

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3290503/33485/en/xenon-reports-q1-2026-financial-results-and-provides-business-update.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Xenon Pharma Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Xenon Pharma Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    01 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/01/3286198/33485/en/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    01 May 2026
    Share Share
    Xenon To Report Q1 2026 Financial Results On May 7, 2026
    Xenon To Report Q1 2026 Financial Results On May 7, 2026

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3285422/33485/en/xenon-to-report-q1-2026-financial-results-on-may-7-2026.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    Xenon To Present At Upcoming Investor Conferences
    Xenon To Present At Upcoming Investor Conferences

    15 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/15/3274427/33485/en/Xenon-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    15 Apr 2026
    Share Share
    Xenon Shares Phase 3 X-TOLE2 and Azetukalner Data
    Xenon Shares Phase 3 X-TOLE2 and Azetukalner Data

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269108/33485/en/Xenon-to-Highlight-Phase-3-X-TOLE2-Long-Term-Data-for-Azetukalner-in-Focal-Onset-Seizures-at-2026-AAN-Annual-Meeting.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Xenon Pharma Closes $747.5M Upsized Offering on Full Option
    Xenon Pharma Closes $747.5M Upsized Offering on Full Option

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255083/33485/en/Xenon-Pharmaceuticals-Announces-Closing-of-747-5-Million-Upsized-Public-Offering-Including-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search